V. Donaldson

发表

Kinin-Releasing Mechanisms in Hemostasis

V. Donaldson, 1980 .

Observations on the ultrastructure of lesions induced in human and guinea pig skin by C 1 esterase and polypeptide from hereditary angioneurotic edema (HANE) plasma.

F. Rosen, K. Willms, V. Donaldson, 1975, Clinical immunology and immunopathology.

Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins.

J. Chao, H. Margolius, R. Jackson, 1984, Journal of Biological Chemistry.

Brief recordings. Rheumatoid arthritis in a patient with Hageman trait.

H. Glueck, V. Donaldson, T. Fleming, 1972, The New England journal of medicine.

A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

R. R. Evans, V. Donaldson, R. Evans, 1963, The American journal of medicine.

Angioedema induced by a peptide derived from complement component C2

F. Rosen, J. Spragg, E. Schneeberger, 1988, The Journal of experimental medicine.

Radioisotopic measurement of plasma kallikrein.

M. Shuman, G. Rodgers, V. Donaldson, 1982, Thrombosis research.

Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization.

F. Rosen, O. Ratnoff, W. Dias da Silva, 1969, The Journal of clinical investigation.

Activation of complement by a monoclonal cryoglobulin associated with cold urticaria.

C. Coltman, J. Costanzi, V. Donaldson, 1969, The Journal of laboratory and clinical medicine.

Hageman Factor: Alterations in Physical Properties during Activation

O. Ratnoff, V. Donaldson, 1965, Science.

ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE.

F. Rosen, V. Donaldson, 1964, The Journal of clinical investigation.

Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor.

V. Donaldson, J. Kleniewski, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Comparison of human high molecular weight kininogen digestion by plasma kallikrein and by plasmin. A revised method of purification of high molecular weight kininogen.

V. Donaldson, J. Kleniewski, 1987, The Journal of laboratory and clinical medicine.

CpG mutations in the reactive site of human C1 inhibitor.

K. Skriver, E. Radziejewska, S. C. Bock, 1989, The Journal of biological chemistry.

Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies.

F. Rosen, D. Bing, R. Harrison, 1985, The Journal of clinical investigation.

Bleeding Syndromes: A Clinical Manual

V. Donaldson, 1961 .

Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.

H. Movat, M. Miller, H. Glueck, 1976, The Journal of laboratory and clinical medicine.

Therapy of "the neurotic edema".

V. Donaldson, 1972, The New England journal of medicine.

THE ENHANCEMENT OF CHLOROFORM-INDUCED PLASMA PROTEOLYTIC ACTIVITY BY EPSILON AMINOCAPROIC ACID

O. Ratnoff, V. Donaldson, 1962, The Journal of experimental medicine.

Hereditary Angioneurotic Edema: Two Genetic Variants

F. Rosen, P. Charache, J. Pensky, 1965, Science.

Angioneurotic edema with acquired C1- inhibitor deficiency and autoantibody to C1- inhibitor: response to plasmapheresis and cytotoxic therapy.

I. Bernstein, D. Bernstein, J. Scinto, 1992, The Journal of laboratory and clinical medicine.

Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity

V. Donaldson, J. Kleniewski, Jozef Kleniewski, 1988, The Journal of experimental medicine.

C1-inhibitor and its genetic alterations in hereditary angioneurotic edema.

V. Donaldson, 1993, International reviews of immunology.

Quantification of Human High-Molecular-Weight Kininogen (HMW-KGN) by Specific Hemagglutination Inhibition Reaction 1

V. Donaldson, J. Kleniewski, 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Fatal myocardial necrosis associated with prothrombin-complex concentrate therapy in hemophilia A.

R. Gruppo, K. Bove, V. Donaldson, 1983, The New England journal of medicine.

MECHANISMS OF ACTIVATION OF C'1 ESTERASE IN HEREDITARY ANGIONEUROTIC EDEMA PLASMA IN VITRO

V. Donaldson, 1968, The Journal of experimental medicine.

Antibody to C1-inhibitor in a patient receiving C1-inhibitor infusions for treatment of hereditary angioneurotic edema with systemic lupus erythematosus reacts with a normal allotype of residue 458 of C1-inhibitor.

J. Bissler, A. Davis, T. Welch, 1996, The Journal of laboratory and clinical medicine.

Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema.

F. Rosen, C. Alper, J. Pensky, 1971, The Journal of clinical investigation.

Serum inhibitor of C'1-esterase in health and disease.

V. Donaldson, 1966, The Journal of laboratory and clinical medicine.

Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.

A. Cardin, D. T. Blankenship, V. Donaldson, 1992, The Journal of laboratory and clinical medicine.

Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization.

R. Huber, E. Nielsen, R. Eddy, 1986, Biochemistry.

Remissions induced in hereditary angioneurotic edema with an attenuated androgen (danazol): correlation between concentrations of C1-inhibitor and the forth and second components of complement.

R. Wyatt, J. S. Pitts, V. Donaldson, 1978, The Journal of laboratory and clinical medicine.

Hereditary angioneurotic edema.

V. Donaldson, 1979, Disease-a-month : DM.

A cluster of mutations within a short triplet repeat in the C1 inhibitor gene.

A. Sheffer, F. Rosen, J. Bissler, 1994, Proceedings of the National Academy of Sciences of the United States of America.

C′l activation in hereditary angioneurotic edema plasma: role of urokinase and inhibitors

V. Donaldson, 1968 .

Studies on the activation of a serum esterase with ether and its relationship to C'l-esterase.

V. Donaldson, 1961, The Journal of clinical investigation.

Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma.

F. Rosen, D. Bing, V. Donaldson, 1977, Transactions of the Association of American Physicians.

Hereditary angioneurotic edema: a clinical survey.

F. Rosen, V. Donaldson, 1966, Pediatrics.

Molecular defects in hereditary angioneurotic edema.

F. Rosen, J. Bissler, M. Cicardi, 1997, Proceedings of the Association of American Physicians.

The challenge of hereditary angioneurotic edema.

V. Donaldson, 1983, The New England journal of medicine.

Interactions of plasma kallikrein and C1-s with normal and dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema: analytic gel studies.

F. Rosen, D. Bing, R. Harrison, 1987, Blood.

A modification of an affinity procedure for purification of human C1- inhibitor that provides a homogeneous stable preparation.

M. Falconieri, V. Donaldson, 1993, Journal of immunological methods.

Some observations on the phylogeny of serum inhibitor of C1 esterase.

J. Pensky, V. Donaldson, 1970, Journal of immunology.

C1- inhibitors and their genes: an update.

J. Bissler, V. Donaldson, 1992, The Journal of laboratory and clinical medicine.

Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.

H. Saito, V. Donaldson, J. Kleniewski, 1977, The Journal of clinical investigation.

Kinin formation in hereditary angioneurotic edema (HANE) plasma.

V. Donaldson, 1973, International archives of allergy and applied immunology.

Lupus-erythematosus-like disease in three unrelated women with hereditary angioneurotic edema.

A. J. Mcadams, E. Hess, V. Donaldson, 1977, Annals of internal medicine.

Asymmetric angioneurotic edema associated with thrombolysis for acute stroke.

A. Pancioli, T. Brott, R. Miller, 1997, Annals of emergency medicine.

Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema.

F. Rosen, M. Klemperer, V. Donaldson, 1968, The Journal of clinical investigation.

C1-inhibitor in hereditary angioneurotic edema: types I and II.

V. Donaldson, 1989, Behring Institute Mitteilungen.

Blood coagulation and related plasma enzymes in inflammation.

V. Donaldson, 1970, Series haematologica.

With Thrombolysis for Acute Stroke

A. Pancioli, T. Brott, V. Donaldson, 1997 .

Kininogen Deficiency and Defective Surface Activation of Blood Coagulation and Fibrinolysis in a Kindred with Fitzgerald Trait

M. Miller, H. Glueck, V. Donaldson, 1975, Thrombosis and Haemostasis.

Some molecular and functional changes in high molecular weight kininogen induced by plasmin and trypsin.

V. Donaldson, J. Kleniewski, C. J. Wagner, 1982, Thrombosis research.

Scission of human apolipoprotein B-100 by kallikrein: characterization of the cleavage site.

J. Kane, J. Schilling, A. Gustafson, 1986, Biochemical and biophysical research communications.

Effect of plasmin in vitro on clotting factors in plasma.

V. Donaldson, 1960, The Journal of laboratory and clinical medicine.

Kinin generation in hereditary angioneurotic edema (H.A.N.E.) plasma.

F. Rosen, D. Bing, V. Donaldson, 1983, Advances in experimental medicine and biology.

SEROTONIN-LIKE ACTIVITY IN BAMBOO EXTRACTS

V. Donaldson, 1982, The Lancet.

Bradykinin inactivation by rabbit serum and butylated hydroxyanisole.

V. Donaldson, 1973, Journal of applied physiology.

and Fitzgerald Trait Clotting Defect EVIDENCE THAT HIGH MOLECULAR WEIGHT KININOGEN AND PREKALLIKREIN EXIST AS A COMPLEX IN NORMAL HUMAN PLASMA

H. Saito, V. Donaldson, J. Kleniewski, 1977 .

Effect of Some Analogues of Bradykinin Upon Vascular Permeability.∗

O. Ratnoff, V. Donaldson, 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Plasmin induced changes in high molecular weight kininogen (HMW-K).

V. Donaldson, J. Kleniewski, C. J. Wagner, 1983, Advances in experimental medicine and biology.

C1-inhibitor: structure/function and biologic role.

K. Aulak, A. Davis, V. Donaldson, 1993, Behring Institute Mitteilungen.

Contiguous deletion and duplication mutations resulting in type 1 hereditary angioneurotic edema

J. Bissler, A. Davis, V. Donaldson, 1994, Human Genetics.

Complexes between C1-inhibitor, kallikrein, high molecular weight kininogen, plasma thromboplastin antecedent, and plasmin in normal human plasma and hereditary angioneurotic edema plasmas containing dysmorphic C1-inhibitors: role of cold activation.

R. Harrison, V. Donaldson, R. Harrison, 1982, Blood.

The role of plasmin in kinin-release by preparations of human thrombin.

V. Donaldson, J. Kleniewski, 1979, Thrombosis research.